eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

While the AI industry spends billions squeezing incremental speed from token-by-token autoregressive models, Inception’s diffusion based generation is the architectural breakthrough that makes high ...

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...

Whether TNK (tenecteplase) benefits patients with acute ischemic stroke treated within 4.5 to 24 hours remains uncertain, and no previous meta-analysis has differentiated between clinical settings ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

Tijo is an engineer, mechanic, and an avid content creator with over 5 years of experience as an automotive journalist. His media and publishing journey began with CarHP and CarIndigo, and soon ...

aDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China bDepartment of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, ...

yDepartment of Stroke Medicine, Royal Victoria Hospital, Belfast, UK zDepartment of Stroke Medicine, Somerset NHS Foundation Trust, Yeovil District Hospital, Yeovil, UK ...

Tenecteplase is an effective thrombolytic agent for eligible patients with stroke who are treated within 4.5 hours after the onset of stroke. However, data regarding the effectiveness of tenecteplase ...

Tiny flecks of plastic inside in the arteries may ramp up the risks of cardiovascular disease. An analysis of artery-clogging plaques in 257 patients found that the presence of these microplastics was ...